A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA/CoA Ratio via Dual Inhibition of PPAT and CPT1A. J. Can. Res. Updates. 2025;14:247-265. doi:10.30683/1929-2279.2025.14.26